logo (2).jpg
ASML reports transactions under its current share buyback program
March 29, 2024 09:00 ET | ASML Netherlands BV
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share...
SB Financial Group, Inc. Announces Schedule for First Quarter 2024 Results
March 29, 2024 09:00 ET | SB Financial Group, Inc.
DEFIANCE, Ohio, March 29, 2024 (GLOBE NEWSWIRE) -- SB Financial Group, Inc. (NASDAQ: SBFG), a diversified financial services company providing full-service community banking, mortgage banking,...
Adagene_Logo_GNW.png
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024 09:00 ET | Adagene Inc.
- Data for masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable (MSS) colorectal cancer...
Logo.jpg
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
March 29, 2024 08:30 ET | Elicio Therapeutics, Inc.
ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual Meeting 2024ELI-007 and ELI-008 preclinical data were accepted for a poster presentation at the AACR...
molecular.jpg
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
March 29, 2024 08:21 ET | Molecular Templates, Inc.
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
BurgerFiAnthonys.png
BurgerFi to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
March 29, 2024 08:00 ET | BurgerFi International
FORT LAUDERDALE, Fla., March 29, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of the nation’s leading fast-casual “better burger” dining...
Gentex-black.jpg
Gentex Schedules First Quarter 2024 Earnings Release Date and Conference Call
March 29, 2024 08:00 ET | Gentex Corporation
Gentex schedules Q1 2024 earnings release and conference call for April 26.
KALA BIO logo.jpg
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024 08:00 ET | KALA BIO, Inc.
-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by year-end 2024 ---- Exploring opportunities to expand KPI-012 into additional corneal indications ---- Cash...
galectin.jpg
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
March 29, 2024 08:00 ET | Galectin Therapeutics Inc.
NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results...